Published in
BioMed Central, Molecular Cancer, 1(20), 2021
DOI: 10.1186/s12943-021-01319-5
Links
Tools
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity
Journal article published in 2021 by
Yann Cheli,
Meri K. Tulic 
,
Najla El Hachem ,
Nicolas Nottet,
Arnaud Jacquel,
Maeva Gesson,
Thomas Strub,
Karine Bille,
Alexandra Picard-Gauci,
Henri Montaudié,
Guillaume E. Beranger,
Thierry Passeron,
Pierre Close,
Corine Bertolotto ,
Robert Ballotti
,
Najla El Hachem ,
Nicolas Nottet,
Arnaud Jacquel,
Maeva Gesson,
Thomas Strub,
Karine Bille,
Alexandra Picard-Gauci,
Henri Montaudié,
Guillaume E. Beranger,
Thierry Passeron,
Pierre Close,
Corine Bertolotto ,
Robert Ballotti
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
An amendment to this paper has been published and can be accessed via the original article.